Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical

$CARLPress releaseSep 15, 2026, 7:00 PM ETRead the release

Carlsmed (Nasdaq: CARL) filed a patent infringement lawsuit against DeGen Medical in the U.S. District Court for the District of South Carolina, Florence Division. The complaint asserts that DeGen infringes eight Carlsmed patents covering its implants, methods and systems, and Carlsmed is seeking injunctive relief plus damages.

Key figures

Patents asserted
8

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.